BMX-HGG: Phase II trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Katherine B. Peters, Adam Louis Cohen, Nicholas A. Butowski, John L. Villano, Pierre Giglio, Tresa McGranahan, Chi Zhang, Timothy Francis Cloughesy, James Emmett Herndon, Patrick Healy, David MacLeod, Sara Penchev, David Silberstein, Ines Batinic-Haberle, Ivan Spasojevic, Shayne Gad, David Radoff, Daniel Barboriak, James Crapo
Institutions: Duke Medical Center, Huntsman Cancer Institute, University of California, San Francisco, University of Kentucky, Markey Cancer Center, The Ohio State University Wexner Medical Center, The Ohio State University, Stanford Cancer Institute, University of Nebraska Medical Center, University of California, Los Angeles, Duke University, Duke Cancer Institute, BioMimetix JV, LLC (United States), Gad Consulting Services (United States)
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3031995321